It addresses the role of AQP4 in this system, its suggested roles in Aβ and tau clearance, and potential as a therapeutic target for Alzheimer’s Disease, as well as other AQP4-related neuropathologies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.